|
|
|
Insider
Information: |
Wilson Jason Douglas |
Relationship: |
Executive VP of Operat... |
City: |
Irving |
State: |
TX |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
12,950 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,232,062 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
12,950 |
|
|
Total
Value |
$2,232,062 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Reata Pharmaceuticals Inc |
RETA |
Executive VP of Operat... |
2019-12-16 |
12,950 |
2016-06-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RETA |
Reata Pharmaceuticals Inc |
Executive VP of Operations |
|
2019-12-16 |
4 |
AS |
$200.17 |
$2,032,591 |
D/D |
(10,000) |
12,950 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Executive VP of Operations |
|
2019-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
15,600 |
22,950 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Executive VP of Operations |
|
2019-10-17 |
4 |
AS |
$170.00 |
$1,700,000 |
D/D |
(10,000) |
7,350 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Executive VP of Operations |
|
2019-10-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
17,350 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Executive VP of Operations |
|
2019-10-15 |
4 |
AS |
$145.55 |
$2,191,956 |
D/D |
(15,000) |
7,350 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Executive VP of Operations |
|
2019-10-15 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
22,350 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Executive VP of Operations |
|
2019-10-14 |
4 |
AS |
$100.00 |
$1,500,000 |
D/D |
(15,000) |
7,350 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Executive VP of Operations |
|
2019-10-14 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
22,350 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Financial Officer |
|
2019-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
4,000 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Financial Officer |
|
2019-08-15 |
4 |
AS |
$72.25 |
$290,735 |
D/D |
(4,000) |
0 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Financial Officer |
|
2019-07-15 |
4 |
AS |
$83.93 |
$338,556 |
D/D |
(4,000) |
0 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Financial Officer |
|
2019-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
4,000 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Financial Officer |
|
2019-06-17 |
4 |
AS |
$82.08 |
$334,177 |
D/D |
(4,000) |
0 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Financial Officer |
|
2019-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
4,000 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Financial Officer |
|
2019-05-15 |
4 |
AS |
$88.74 |
$359,631 |
D/D |
(4,000) |
0 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Financial Officer |
|
2019-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
4,000 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Financial Officer |
|
2019-04-15 |
4 |
AS |
$82.54 |
$335,262 |
D/D |
(4,000) |
0 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Financial Officer |
|
2019-04-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
4,000 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Financial Officer |
|
2019-03-19 |
4 |
S |
$93.18 |
$2,655,209 |
D/D |
(28,396) |
0 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Financial Officer |
|
2019-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
28,396 |
28,396 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Financial Officer |
|
2019-03-18 |
4 |
AS |
$95.11 |
$152,556 |
D/D |
(1,604) |
0 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Financial Officer |
|
2019-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,604 |
1,604 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Financial Officer |
|
2019-03-15 |
4 |
AS |
$93.62 |
$374,470 |
D/D |
(4,000) |
0 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Financial Officer |
|
2019-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
4,000 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Financial Officer |
|
2019-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
4,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|